Status:
COMPLETED
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Lead Sponsor:
Alcon Research
Conditions:
Open-angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.
Eligibility Criteria
Inclusion
- 18 years of age or older
- Diagnosis of open-angle glaucoma
- Other protocol-defined inclusion criteria may apply
Exclusion
- Under 18
- Pregnant
- Other protocol-defined exclusion criteria may apply
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
523 Patients enrolled
Trial Details
Trial ID
NCT00314158
Start Date
November 1 2005
End Date
January 1 2007
Last Update
November 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
United States Investigative Sites
Fort Worth, Texas, United States, 76134